Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer

Breast cancer is the most common female cancer, affecting approximately one in eight women during their lifetime in North America and Europe. Receptor Activator of NF-kB Ligand (RANKL), its receptor RANK and the natural antagonist osteoprotegerin (OPG) are essential regulators of bone resorption. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Kiechl, Stefan, Schramek, Daniel, Widschwendter, Martin, Fourkala, Evangelia-Ourania, Zaikin, Alexey, Jones, Allison, Jaeger, Bernadette, Rack, Brigitte, Janni, Wolfgang, Scholz, Christoph, Willeit, Johann, Weger, Siegfried, Mayr, Agnes, Teschendorff, Andrew, Rosenthal, Adam, Fraser, Lindsay, Philpott, Susan, Dubeau, Louis, Keshtgar, Mohammed, Roylance, Rebecca, Jacobs, Ian J., Menon, Usha, Schett, Georg, Penninger, Josef M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354797/
https://ncbi.nlm.nih.gov/pubmed/28002811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars